Arghavan Zebardast

Arghavan Zebardast

Auto-generated profile, based on publicly available information

Arghavan Zebardast

Affiliation Virology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2023 in Cell Biology International
Verified
Journal Article
Closed access
AZArghavan Zebardast
Arghavan Zebardast
AHAli Hasanzadeh
Ali Hasanzadeh
SSSeyedeh Arefeh Ebrahimian Shiadeh
Seyedeh Arefeh Ebrahimian Shiadeh
MTMehdi Tourani
Mehdi Tourani
YYYousef Yahyapour
Yousef Yahyapour

28 January 2021 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
AZArghavan Zebardast
Arghavan Zebardast
STSadra S. Tehrani
Sadra S. Tehrani
TLTayebeh Latifi
Tayebeh Latifi
FSFarzin Sadeghi
Farzin Sadeghi


23 August 2024 in Virology Journal
Verified
Journal Article
Open access
PDF file
ALArash Letafati
Arash Letafati
ZTZahra Taghiabadi
Zahra Taghiabadi
MRMahshid Roushanzamir
Mahshid Roushanzamir
BMBahar Memarpour
Bahar Memarpour
SSSaba Seyedi
Saba Seyedi
MNMehdi Norouzi
Mehdi Norouzi
The hepatitis E virus (HEV) is a major cause of acute viral hepatitis worldwide. HEV is classified into eight genotypes, labeled HEV-1 through HEV-8. Genotypes 1 and 2 exclusively infect humans, while genotypes 3, 4, and 7 can infect both humans and animals. In contrast, genotypes 5, 6, and 8 are restricted to infecting animals. While most individuals with a strong immune system experience a self-limiting infection, those who are immunosuppressed may develop chronic hepatitis. Pregnant women are particularly vulnerable to severe illness and mortality due to HEV infection. In addition to liver-related complications, HEV can also cause extrahepatic manifestations, including neurological disorders. The immune response is vital in determining the outcome of HEV infection. Deficiencies in T cells, NK cells, and antibody responses are linked to poor prognosis. Interestingly, HEV itself contains microRNAs that regulate its replication and modify the host’s antiviral response. Diagnosis of HEV infection involves the detection of HEV RNA and anti-HEV IgM/IgG antibodies. Supportive care is the mainstay of treatment for acute infection, while chronic HEV infection may be cleared with the use of ribavirin and pegylated interferon. Prevention remains the best approach against HEV, focusing on sanitation infrastructure improvements and vaccination, with one vaccine already licensed in China. This comprehensive review provides insights into the spread, genotypes, prevalence, and clinical effects of HEV. Furthermore, it emphasizes the need for further research and attention to HEV, particularly in cases of acute hepatitis, especially among solid-organ transplant recipients.

14 October 2021 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
AZArghavan Zebardast
Arghavan Zebardast
PHParastoo Hosseini
Parastoo Hosseini
AHAli Hasanzadeh
Ali Hasanzadeh
TLTayebeh Latifi
Tayebeh Latifi

1 September 2024
Verified
Preprint
Open access
AZArqavan Zebardast
Arqavan Zebardast
KSKaveh Sadeghi
Kaveh Sadeghi
ANAhmad Nejati
Ahmad Nejati
SZSevrin Zadheidar
Sevrin Zadheidar
MNMohammad Hossein Najmi
Mohammad Hossein Najmi
TMTalat Mokhtari-Azad
Talat Mokhtari-Azad
Background: Severe acute respiratory infection (SARI) remains one of the leading causes of morbidity and mortality worldwide. Multiple respiratory viral pathogens can cause this infection. Sequencing technologies hold great promise for detecting viral pathogens. This study aimed to develop and validate a method for the multiplex detection of SARI-related viruses (SARS-CoV-2, Influenza A (H1N1, H3N2), Influenza B, human respiratory syncytial virus, human adenoviruses, human enteroviruses, and human parainfluenza viruses) using a nanopore next-generation sequencing method. Methods: Following genome extraction from oropharyngeal swab samples and conventional RT-PCR assays, the libraries were barcoded and sequenced by the MinION flow cell. The sensitivity and specificity were assessed using various serial dilutions of samples and different primer pools, respectively. NGS data analysis, including adaptor trimming, assembly, mapping, and the generation of consensus sequences, was carried out using bioinformatic tools. Finally, the protocol was validated by evaluating with known positive samples. Results: During 12 hours of MinION sequencing, 711,000 reads passed the quality filters (Q-score>7). 11 out of 12 target genes were successfully identified in clinical samples, with more than 90% coverage for most viruses. All the viruses detected by Q30 value of more than 1%. The detection limit was measured for SARS-CoV-2, Influenza A (H1N1, H3N2), Influenza B, and human respiratory syncytial virus. The platform showed 99.9% specificity in detection and was validated by 20 clinical samples. Conclusion: This study developed and validated a novel multiplex detection method that made it possible to identify SARI-related respiratory viruses in a clinical laboratory setting.